Myasthenia gravis: vizsgálatok itt: Egyesült Királyság

In Egyesült Királyság 10 Also abroad 123

10 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

2/3. fázisTaking people
A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
Where
Glasgow, London
Életkor
12 év to 17 év
People
8 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT06055959 · EU 2022-502072-23-00
2/3. fázisCsak meghívásos
Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis
Where
London, Oxford
Életkor
2 év to 18 év
People
12 worldwide
Run by
argenx
See details and how to joinNCT05374590 · EU 2023-507379-23-00
2. fázisTaking people
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
Where
Oxford
Életkor
2 év to 17 év
People
15 worldwide
Run by
Amgen
See details and how to joinNCT06987539 · EU 2025-520993-20-00
3. fázisTaking people
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Where
London, Nottingham, Sheffield
Életkor
18 év and over
People
264 worldwide
Run by
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
See details and how to joinNCT06463587 · EU 2023-507746-83-00
3. fázisCsak meghívásos
An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
Where
Glasgow, London
Életkor
12 év to 17 év
People
8 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT06435312 · EU 2022-502073-42-00
2/3. fázisTaking people
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
Where
Oxford
Életkor
2 év to 17 év
People
12 worldwide
Run by
argenx
See details and how to joinNCT06392386 · EU 2023-506159-12-00
3. fázisTaking people
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Where
Birmingham, Glasgow, London
Életkor
18 év to 80 év
People
231 worldwide
Run by
Immunovant Sciences GmbH
See details and how to joinNCT07039916 · EU 2024-515979-35-00
2/3. fázisTaking people
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Where
Cambridge, London
Életkor
18 év to 75 év
People
66 worldwide
Run by
Kyverna Therapeutics
See details and how to joinNCT06193889 · EU 2023-509892-17-00
No phaseTaking people
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Where
London
People
75 worldwide
Run by
Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06312644
No phaseTaking people
Vitaccess Real MG Registry
Where
Birmingham, London
Életkor
18 év and over
People
600 worldwide
Run by
Vitaccess Ltd
See details and how to joinNCT06064461